207 related articles for article (PubMed ID: 35457693)
21. Aviator's Heart: A Case of Athlete's Heart in an Active Duty Male Naval Aviator.
Ryaboy IV; Watts JA; Barnwell ML
Mil Med; 2018 Nov; 183(11-12):e783-e786. PubMed ID: 29860439
[TBL] [Abstract][Full Text] [Related]
22. Impact of revised Task Force Criteria: distinguishing the athlete's heart from ARVC/D using cardiac magnetic resonance imaging.
Luijkx T; Velthuis BK; Prakken NH; Cox MG; Bots ML; Mali WP; Hauer RN; Cramer MJ
Eur J Prev Cardiol; 2012 Aug; 19(4):885-91. PubMed ID: 21690305
[TBL] [Abstract][Full Text] [Related]
23. Myocardial fibrosis in athletes-Current perspective.
Małek ŁA; Bucciarelli-Ducci C
Clin Cardiol; 2020 Aug; 43(8):882-888. PubMed ID: 32189357
[TBL] [Abstract][Full Text] [Related]
24. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
[TBL] [Abstract][Full Text] [Related]
25. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
Pöyhönen P; Kivistö S; Holmström M; Hänninen H
BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of athlete's heart and hypertrophic cardiomyopathy by the fractal dimension of left ventricular trabeculae.
Vilades D; Garcia-Moll X; Gomez-Llorente M; Pujadas S; Ferrero-Gregori A; Doñate T; Mirabet S; Leta R; Pons-Lladó G; Carreras F; Cinca J
Int J Cardiol; 2021 May; 330():232-237. PubMed ID: 33621621
[TBL] [Abstract][Full Text] [Related]
27. The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Highly Trained Athletes.
Gati S; Sharma S; Pennell D
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):247-259. PubMed ID: 29413645
[TBL] [Abstract][Full Text] [Related]
28. Cardiac magnetic resonance imaging features prognostic information in patients with suspected myocardial infarction with non-obstructed coronary arteries.
Emrich T; Kros M; Schoepf UJ; Geyer M; Mildenberger P; Kloeckner R; Wenzel P; Varga-Szemes A; Düber C; Münzel T; Kreitner KF
Int J Cardiol; 2021 Mar; 327():223-230. PubMed ID: 33309758
[TBL] [Abstract][Full Text] [Related]
29. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1048-1058. PubMed ID: 24011774
[TBL] [Abstract][Full Text] [Related]
30. Differentiating Athlete's Heart from Left Ventricle Cardiomyopathies.
Abulí M; de la Garza MS; Sitges M
J Cardiovasc Transl Res; 2020 Jun; 13(3):265-273. PubMed ID: 32410209
[TBL] [Abstract][Full Text] [Related]
31. Importance of cardiac magnetic resonance findings in the diagnosis of left dominant arrythmogenic cardiomyopathy.
Feliu E; Moscicki R; Carrillo L; García-Fernández A; Martínez Martínez JG; Ruiz-Nodar JM
Rev Esp Cardiol (Engl Ed); 2020 Nov; 73(11):885-892. PubMed ID: 31992505
[TBL] [Abstract][Full Text] [Related]
32. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.
Habib M; Adler A; Fardfini K; Hoss S; Hanneman K; Rowin EJ; Maron MS; Maron BJ; Rakowski H; Chan RH
JACC Cardiovasc Imaging; 2021 May; 14(5):947-958. PubMed ID: 33248971
[TBL] [Abstract][Full Text] [Related]
33. The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.
Czimbalmos C; Csecs I; Toth A; Kiss O; Suhai FI; Sydo N; Dohy Z; Apor A; Merkely B; Vago H
PLoS One; 2019; 14(2):e0211624. PubMed ID: 30763323
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular Magnetic Resonance and Sport Cardiology: a Growing Role in Clinical Dilemmas.
Maestrini V; Torlasco C; Hughes R; Moon JC
J Cardiovasc Transl Res; 2020 Jun; 13(3):296-305. PubMed ID: 32436168
[TBL] [Abstract][Full Text] [Related]
35. Advanced cardiac imaging in athlete's heart: unravelling the grey zone between physiologic adaptation and pathology.
Palmisano A; Darvizeh F; Cundari G; Rovere G; Ferrandino G; Nicoletti V; Cilia F; De Vizio S; Palumbo R; Esposito A; Francone M
Radiol Med; 2021 Dec; 126(12):1518-1531. PubMed ID: 34420142
[TBL] [Abstract][Full Text] [Related]
36. Myocardial Fibrosis in Competitive Triathletes Detected by Contrast-Enhanced CMR Correlates With Exercise-Induced Hypertension and Competition History.
Tahir E; Starekova J; Muellerleile K; von Stritzky A; Münch J; Avanesov M; Weinrich JM; Stehning C; Bohnen S; Radunski UK; Freiwald E; Blankenberg S; Adam G; Pressler A; Patten M; Lund GK
JACC Cardiovasc Imaging; 2018 Sep; 11(9):1260-1270. PubMed ID: 29248656
[TBL] [Abstract][Full Text] [Related]
37. Assessment of myocardial changes in athletes with native T1 mapping and cardiac functional evaluation using 3 T MRI.
Görmeli CA; Görmeli G; Yağmur J; Özdemir ZM; Kahraman AS; Çolak C; Özdemir R
Int J Cardiovasc Imaging; 2016 Jun; 32(6):975-81. PubMed ID: 26920720
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of patients with and without cardiac magnetic resonance imaging abnormalities presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA).
Tayal B; Freeman P; Ericsson F; Kragholm KH; Andersen NH; Hagendorff A; Aaroe J; Sogaard P; Zaremba T
Acta Cardiol; 2021 Sep; 76(7):760-768. PubMed ID: 32594904
[TBL] [Abstract][Full Text] [Related]
39. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and Prognostic Value of Cardiovascular Magnetic Resonance in Neuromuscular Cardiomyopathies.
Almogheer B; Antonopoulos AS; Azzu A; Al Mohdar S; Vlachopoulos C; Pantazis A; Mohiaddin RH
Pediatr Cardiol; 2022 Jan; 43(1):27-38. PubMed ID: 34342696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
